Combination Chemotherapy and Dexrazoxane Followed by Surgery and Radiation Therapy in Treating Patients With Advanced Soft Tissue Sarcoma or Recurrent Bone Sarcoma
Condition(s):SarcomaLast Updated:August 28, 2014Terminated
Hide Studies Not Open or Pending
Condition(s):SarcomaLast Updated:August 28, 2014Terminated
Condition(s):Cardiac Toxicity; Leukemia; LymphomaLast Updated:June 6, 2013Completed
Condition(s):Ewing’s SarcomaLast Updated:August 1, 2018Completed
Condition(s):Childhood Solid Neoplasm; Recurrent Childhood Anaplastic Large Cell Lymphoma; Recurrent NeuroblastomaLast Updated:January 5, 2024Completed
Condition(s):SarcomaLast Updated:June 25, 2013Completed
Condition(s):Advanced Soft Tissue SarcomaLast Updated:July 15, 2020Terminated
Condition(s):Myelodysplastic Syndromes, de Novo; Myelodysplastic Syndromes, Secondary; Myelodysplastic Syndromes, Previously Treated; Treatment-Related Acute Myeloid Leukemia; Therapy-Related Myelodysplastic Syndrome; Acute Lymphoblastic Leukemia, in Relapse; Acute Lymphoblastic Leukemia With Failed Remission; Lymphoblastic Lymphoma, in Relapse; Lymphoblastic Lymphoma, Refractory; Acute Leukemia of Ambiguous Lineage in Relapse; Acute Leukemia of Ambiguous LineageLast Updated:December 5, 2023Recruiting
Condition(s):Osteosarcoma; Lung MetastasesLast Updated:December 10, 2013Terminated
Condition(s):Acute Lymphoblastic LeukemiaLast Updated:April 25, 2013Completed
Condition(s):Relapsed Acute Lymphoblastic Leukemia; Allergy to PEG e.Coli Asparaginase; Allergy to Native e.Coli AsparaginaseLast Updated:February 19, 2019Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.